1. Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status
- Author
-
Xuguang Zhang, Susan C. McGeoch, Alexandra M. Johnstone, Alan A. Sneddon, Niamh O'Kennedy, Sandra MacRury, Prakash Abraham, Ian L. Megson, Baukje de Roos, Gerald E. Lobley, Grietje Holtrop, and Donald W. M. Pearson
- Subjects
Adult ,Blood Platelets ,Male ,medicine.medical_specialty ,Type 2 diabetes ,Pathogenesis ,Leukocyte Count ,Cell-Derived Microparticles ,Risk Factors ,Diabetes mellitus ,Internal medicine ,Humans ,Medicine ,Platelet ,Obesity ,Platelet activation ,Aged ,Hematology ,business.industry ,Type 2 Diabetes Mellitus ,Middle Aged ,Atherosclerosis ,Platelet Activation ,medicine.disease ,Endocrinology ,Diabetes Mellitus, Type 2 ,Female ,Cardiology and Cardiovascular Medicine ,business ,Biomarkers ,Diabetic Angiopathies - Abstract
This study investigated the impact of either type 2 diabetes or obesity, separately or in combination, on the absolute amounts of microparticles (MP) and the pathways by which these are associated with either condition. The concentrations of circulating MP derived from platelets (PMP), leukocytes (LMP) and monocytes (MMP), together with their specific activation markers, were compared in 30 subjects who were characterised across 4 cohorts as obese or type 2 diabetes. The subjects with type 2 diabetes had elevated concentrations of total PMP (P = 0.003), and PMP that were fibrinogen-positive (P = 0.04), tissue factor-positive (P
- Published
- 2013
- Full Text
- View/download PDF